On July 2, 2024, our intraoperative nerve stimulation monitoring system, registered under National Medical Products Administration registration number 20243071197, received China’s first Category III medical-device registration for a high-channel intraoperative neuromonitoring system designed for orthopedic and neurosurgical procedures.
The system was developed entirely with independent intellectual property rights and represented another milestone in the development of domestic electrophysiology equipment.

The system featured:
The system supported neurophysiological monitoring and protection in orthopedic, neurosurgical, head and neck surgery and other surgical settings. Its high-channel configuration expanded the range of neurophysiological signals available for intraoperative monitoring.
The product also received support from the Shanghai Municipal Commission of Economy and Informatization’s 2022–2023 High-Quality Development Special Project for Biomedicine, under the project titled “Industrialization and Application of High-End Intraoperative Nerve Stimulation Monitoring Equipment”.

Our development in Category III intraoperative neuromonitoring began with a series of regulatory milestones:
Together, these milestones reflected our continued work to develop an integrated intraoperative neuromonitoring portfolio covering monitoring equipment, specialized airway products and disposable electrodes.
The Category III registration of our 32+256-channel intraoperative nerve stimulation monitoring system marked an important step in the development of domestic high-channel IONM equipment.
We continued to focus on technical innovation, regulatory development and clinical collaboration. Through ongoing research and cooperation with clinical partners, we continued to advance intraoperative neurophysiological monitoring solutions for relevant surgical settings.
Copyright © NCC Medical Co., Ltd. - Privacy policy